Abstract | BACKGROUND: METHODS: RESULTS:
Malaria prevalence was low. Between enrolment and delivery, antibodies to recombinant antigens declined in both groups (p<0.0001). In contrast, median levels of opsonizing antibodies did not change, although levels for some individuals changed significantly. In multivariate analysis, the malaria prevention regimen did not influence antibody levels. CONCLUSION: Different preventive anti-malarial chemotherapy regimens used during pregnancy had limited impact on malarial-immunity in a low-transmission region of Papua New Guinea. TRIAL REGISTRATIONS: NCT01136850.
|
Authors | Andrew Teo, Wina Hasang, Louise M Randall, Holger W Unger, Peter M Siba, Ivo Mueller, Graham V Brown, Stephen J Rogerson |
Journal | Malaria journal
(Malar J)
Vol. 14
Pg. 215
(May 26 2015)
ISSN: 1475-2875 [Electronic] England |
PMID | 26006260
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Protozoan
- Antimalarials
- Drug Combinations
- fanasil, pyrimethamine drug combination
- Azithromycin
- Sulfadoxine
- Chloroquine
- Pyrimethamine
|
Topics |
- Adult
- Antibodies, Protozoan
(blood)
- Antimalarials
(administration & dosage, adverse effects)
- Azithromycin
(administration & dosage, adverse effects)
- Chloroquine
(administration & dosage, adverse effects)
- Drug Combinations
- Erythrocytes
- Female
- Humans
- Malaria, Falciparum
(prevention & control)
- Papua New Guinea
- Pregnancy
- Pregnancy Complications, Parasitic
(chemically induced, immunology)
- Pyrimethamine
(administration & dosage, adverse effects)
- Sulfadoxine
(administration & dosage, adverse effects)
- Young Adult
|